Bio-Rad Laboratories Inc (BIO)
331.77
-0.33
(-0.10%)
USD |
NYSE |
Sep 27, 16:00
331.73
-0.04
(-0.01%)
After-Hours: 20:00
Bio-Rad Laboratories SG&A Expense (TTM): 817.95M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 817.95M |
March 31, 2024 | 831.05M |
December 31, 2023 | 841.72M |
September 30, 2023 | 846.80M |
June 30, 2023 | 856.72M |
March 31, 2023 | 856.69M |
December 31, 2022 | 827.82M |
September 30, 2022 | 837.29M |
June 30, 2022 | 842.33M |
March 31, 2022 | 847.96M |
December 31, 2021 | 877.12M |
September 30, 2021 | 873.11M |
June 30, 2021 | 855.12M |
March 31, 2021 | 830.96M |
December 31, 2020 | 798.80M |
September 30, 2020 | 795.28M |
June 30, 2020 | 798.74M |
March 31, 2020 | 810.74M |
December 31, 2019 | 824.62M |
September 30, 2019 | 824.49M |
June 30, 2019 | 824.07M |
March 31, 2019 | 833.23M |
December 31, 2018 | 834.78M |
September 30, 2018 | 822.48M |
June 30, 2018 | 819.45M |
Date | Value |
---|---|
March 31, 2018 | 821.52M |
December 31, 2017 | 806.79M |
September 30, 2017 | 823.05M |
June 30, 2017 | 826.34M |
March 31, 2017 | 819.38M |
December 31, 2016 | 814.70M |
September 30, 2016 | 789.85M |
June 30, 2016 | 775.84M |
March 31, 2016 | 763.15M |
December 31, 2015 | 761.99M |
September 30, 2015 | 776.38M |
June 30, 2015 | 791.49M |
March 31, 2015 | 794.48M |
December 31, 2014 | 808.20M |
September 30, 2014 | 815.25M |
June 30, 2014 | 814.94M |
March 31, 2014 | 814.43M |
December 31, 2013 | 798.07M |
September 30, 2013 | 772.35M |
June 30, 2013 | 730.25M |
March 31, 2013 | 697.17M |
December 31, 2012 | 682.55M |
September 30, 2012 | 668.30M |
June 30, 2012 | 685.03M |
March 31, 2012 | 699.51M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
795.28M
Minimum
Sep 2020
877.12M
Maximum
Dec 2021
834.77M
Average
834.17M
Median
SG&A Expense (TTM) Benchmarks
Agilent Technologies Inc | 1.564B |
Bruker Corp | 805.40M |
Avantor Inc | 1.585B |
Azenta Inc | 305.65M |
Harvard Bioscience Inc | 45.99M |